Kush Parmar

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Kush Parmar
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kush Parmar:

Form 4 holding Director

Homology Medicines, Inc.

Security class
Option (Right to Buy)
Shares / value
18,000
Estimated value
$241,560
Report date
15 Jun 2022
Price
$13.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Rallybio Corp

Security class
Option (Right to Buy)
Shares / value
16,500
Estimated value
$29,205
Report date
15 May 2024
Price
$1.77
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Vor Biopharma Inc.

Security class
Stock Option (right to buy)
Shares / value
16,911
Estimated value
Report date
14 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Akouos, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
30 Nov 2022
Price
$12.50
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Akouos, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
01 Dec 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kush Parmar

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .